The Clinical efficacy of Wenxinkeli joint βblocker therapy in patients of coronary heart disease with ventricular premature beats

Objective To investigate the clinical efficacy of the Wenxinkeli and β-blocker metoprolol treatment of coronary artery disease complicated by premature ventricular contractions. Methods Coronary heart disease hospital in 2009 from January to December 2011 concurrent premature ventricular contractions in patients with 126 cases were randomly divided into two groups to observe a group of 60 patients (M group) and a control group of 66 cases (group A) . The control group was given amiodarone treatment,observed in patients given the metoprolol Wenxinkeli treatment,two groups of patients were treated for 4 weeks. Results Remarkable efficiency of the clinical symptoms of the W group and total efficiency of 68. 3% and 90. 0% respectively,significantly higher than 54. 5% and 81. 8% in group A; W electrocardiogram total effective rate was 93.3.0% from 84.8% in Group A,the differencewere statistically significant (P 0.05) W group ECG markedly effective rate was 66. 7% and 63. 6% in group A,the difference was not statistically significant (P 0.05) . Conclusion Wenxinkeli combined with β blockers metoprolol can significantly improve coronary heart disease with ventricular premature beats in patients with clinical symptoms,significant clinical effect,and no arrhythmogenic effect,safe,worthy of clinical learn.